Isatuximab
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38, a protein highly expressed on hematological malignant cells, including those in multiple myeloma (MM) . Isatuximab has antitumor activity via multiple biological mechanisms, including antibody-dependent cellular-mediated cytotoxicity, complement-dependent cytotoxicity, antibody-dependent cellular phagocytosis, and direct induction of apoptosis without crosslinking. Isatuximab also directly inhibits CD38 ectoenzyme activity, which is implicated in many cellular functions[1][2].
Product Specifications
CAS Number
1461640-62-9
Product Name Alternative
Ch38SB19; hu38SB19; SAR-650984
UNSPSC
12352203
Target
Apoptosis
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/isatuximab.html
Purity
98.5
Solubility
H2O
Smiles
[Isatuximab]
Molecular Weight
(145.2 kDa)
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
Store at 4°C for 2 years, do not freeze
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human SUN domain-containing protein 3 (SUN3), partial
Recombinant Human SUN domain-containing protein 3 (SUN3), partial
Recombinant Human SUN domain-containing protein 3 (SUN3), partial
Mapk11 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)
Zinc Finger Protein 562 (ZNF562) Antibody (FITC)